NEA Management Company, LLC - Q4 2014 holdings

$2.06 Billion is the total value of NEA Management Company, LLC's 35 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 42.9% .

 Value Shares↓ Weighting
GRPN SellGROUPON INC$364,869,000
+0.5%
44,172,953
-18.7%
17.69%
-4.1%
ARDX SellARDELYX INC$106,184,000
+12.9%
5,621,199
-15.1%
5.15%
+7.7%
CVT SellCVENT INC$83,429,000
-34.2%
2,996,738
-40.0%
4.04%
-37.2%
WIFI SellBOINGO WIRELESS INC$26,534,000
-16.7%
3,459,460
-22.6%
1.29%
-20.5%
TSPT ExitTRANSCEPT PHARMACEUTICALS INC$0-2,086,755
-100.0%
-0.22%
ExitALIMERA SCIENCES INC$0-2,255,639
-100.0%
-0.62%
NKTR ExitNEKTAR THERAPEUTICS$0-1,825,600
-100.0%
-1.12%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-01-26
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GLYCOMIMETICS INC39Q3 20237.6%
AURINIA PHARMACEUTICALS INC37Q3 20235.0%
CHAMPIONS ONCOLOGY INC33Q3 20231.2%
LEXICON PHARMACEUTICALS INC32Q3 20232.0%
ADAPTIMMUNE THERAPEUTICS PLC31Q3 20239.3%
TREVENA INC31Q3 20213.3%
AKARI THERAPEUTICS PLC31Q2 20230.3%
ARDELYX INC29Q3 202111.9%
RIGEL PHARMACEUTICALS INC29Q2 20200.6%
EPIZYME INC28Q1 20209.6%

View NEA Management Company, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-10
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14

View NEA Management Company, LLC's complete filings history.

Compare quarters

Export NEA Management Company, LLC's holdings